Safety and Efficacy of Autoimmune Cell Therapy for Patients With Hepatocellular Carcinoma
Clinical trial NCT05105815 · UNKNOWN
Trial details
- NCT number
- NCT05105815
- Sponsor
- Huashan Hospital
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-31
- Primary completion
- 2023-12-31
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.